TCR Cure Funding: $47M Raised, Series C (2022)

TCR Cure funding overview

TCR Cure is based in Hong Kong Sar. TCR Cure has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2022. The round record for TCR Cure runs through 2022; nothing later has been disclosed. Investors on record include Emerging Technology Partners, CCB Financial Assets Investment, 德同资本, Founder Hesheng Investment Co., Ltd.. 4 distinct backers are named across the disclosed rounds.

TCR Cure at a glance

Total raised: $47M
Latest round: Series C
Latest round date: February 2022
Headquarters: Hong Kong Sar
Notable investors: Emerging Technology Partners, CCB Financial Assets Investment, 德同资本, Founder Hesheng Investment Co., Ltd.

Frequently asked about TCR Cure funding

How much has TCR Cure raised?: TCR Cure has raised $47M in total disclosed funding across the rounds on record.
Who has invested in TCR Cure?: Emerging Technology Partners, CCB Financial Assets Investment, 德同资本, Founder Hesheng Investment Co., Ltd. are named among the investors backing TCR Cure.
What was the latest TCR Cure funding round?: The most recent disclosed round is a Series C, announced in February 2022.
Where is TCR Cure based?: TCR Cure is based in Hong Kong Sar.
When did TCR Cure last raise?: The last disclosed TCR Cure round closed in February 2022 at Series C.

TCR Cure totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hong Kong Sar below to benchmark round size and investor mix.

TCR Cure Funding: $47M Raised, Series C (2022)

TCR Cure funding overview

TCR Cure at a glance

Frequently asked about TCR Cure funding

Companies related to TCR Cure (37)

Browse related funding lists (3)